NYSE · Financial Statements

Zimmer Biomet Holdings, Inc. (ZBH) Revenue, Earnings & Financial Statements

$102.09 NYSE: ZBH Market Cap $19.32B

Data as of Nov 17, 2026 close · Statements through the quarter ended Sep 2026 · Source: Financial Modeling Prep (methodology)

Zimmer Biomet Holdings, Inc. most recently reported annual revenue of $8.2B, net profit of $705.0M. Revenue grew at an average annual rate of 6.1% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Zimmer Biomet Holdings, Inc.: Revenue rose from $7.7B in 2016 to $8.2B in 2025, a change of +7.4% over 9 years; net profit was positive in 8 of 10 reported years; operating margin moved from 10.7% to 16.6%, a shift of +5.8 percentage points; the most recent year shows net profit of $705.0M.

Income Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Revenue$7.7B$7.8B$7.9B$8.0B$6.1B$6.8B$6.9B$7.4B$7.7B$8.2B
Operating Expenses$6.8B$7.0B$7.9B$6.8B$6.0B$6.0B$6.2B$6.1B$6.4B$6.9B
Operating Profit$821.0M$799.0M$34.0M$1.1B$83.0M$860.0M$696.0M$1.3B$1.3B$1.4B
Operating Margin10.7%10.2%0.4%14.3%1.4%12.6%10.0%17.3%16.7%16.6%
Other Income−$421.0M−$335.0M−$305.0M−$232.0M−$188.0M−$361.0M−$293.0M−$210.0M−$249.0M−$531.0M
Interest$355.0M$325.0M$289.0M$227.0M$212.0M$208.0M$165.0M$201.0M$218.0M$293.0M
Depreciation$1.0B$1.1B$1.0B$1.0B$898.0M$938.0M$926.0M$952.0M$996.0M$1.1B
Profit Before Tax$400.0M$465.0M−$271.0M$906.0M−$105.0M$499.0M$404.0M$1.1B$1.0B$831.0M
Tax rate (%)23.8%-290.3%-39.9%-24.9%91.3%10.7%27.8%4.0%12.7%15.1%
Net Profit$306.0M$1.8B−$379.0M$1.1B−$139.0M$402.0M$231.0M$1.0B$904.0M$705.0M
EPS$1.46$8.77−$1.81$5.31−$0.65$1.85$1.10$4.88$4.43$3.55

Quarterly Results — Last 12 Quarters (USD millions)

8 duplicate period labels in the source data were collapsed.

MetricDec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26Sep '26
Revenue$1.9B$1.9B$1.9B$1.8B$2.0B$1.9B$2.1B$2.0B$2.2B$2.1B$2.2B$2.1B
Operating Expenses$1.6B$1.6B$1.6B$1.5B$1.6B$1.6B$1.8B$1.6B$2.0B$1.7B$1.9B$1.8B
Operating Profit$354.0M$266.0M$351.0M$280.0M$389.0M$292.0M$300.0M$351.0M$288.0M$373.0M$326.0M$308.0M
Operating Margin18.3%14.1%18.1%15.3%19.2%15.3%14.4%17.6%12.8%17.9%15.0%14.9%
Interest$50.0M$51.0M$51.0M$54.0M$62.0M$66.0M$79.0M$75.0M$72.0M$69.0M$73.0M$75.0M
Profit Before Tax$285.0M$215.0M$302.0M$230.0M$289.0M$229.0M$225.0M$279.0M$98.0M$301.0M$255.0M$230.0M
Tax rate (%)-47.5%19.7%19.6%-8.2%16.9%20.3%31.7%17.2%-40.7%20.9%21.8%16.2%
Net Profit$419.0M$172.0M$243.0M$249.0M$240.0M$182.0M$153.0M$231.0M$140.0M$238.0M$198.0M$192.0M
EPS$2.01$0.84$1.18$1.23$1.20$0.91$0.77$1.16$0.70$1.22$1.03$1.00

Over the 10 years reported for Zimmer Biomet Holdings, Inc., borrowings decreased from $11.2B in 2016 to $7.5B in 2025, cash stood at $592.0M in the latest year, shareholders' equity was $3.0M, current assets covered current liabilities 1.98 times.

Balance Sheet — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Total Assets$26.7B$26.0B$24.1B$24.6B$24.4B$23.5B$21.1B$21.5B$21.4B$23.1B
Current Assets$4.7B$4.6B$4.4B$4.7B$5.1B$4.9B$4.4B$4.6B$4.7B$5.1B
Cash$634.0M$524.0M$543.0M$618.0M$802.0M$378.0M$376.0M$416.0M$526.0M$592.0M
Inventory$2.0B$2.1B$2.3B$2.4B$2.5B$2.1B$2.1B$2.4B$2.2B$2.3B
Receivables$1.6B$1.5B$1.3B$1.4B$1.5B$1.3B$1.4B$1.4B$1.5B$1.7B
Fixed Assets$2.0B$2.0B$2.0B$2.1B$2.0B$1.8B$1.9B$2.1B$2.0B$2.2B
Capital Work in Progress$0$0$0$0$0$0$0$0$0$0
Investments$0$0$0$0$0$28.0M$17.0M$32.0M$73.0M$39.0M
Other Assets$10.6B$10.7B$9.6B$9.6B$9.3B$8.9B$8.6B$8.8B$9.0B$9.9B
Total Liabilities$17.0B$14.3B$12.9B$12.2B$12.2B$10.8B$9.0B$9.0B$8.9B$10.4B
Current Liabilities$2.4B$3.1B$2.4B$3.4B$2.6B$3.5B$2.4B$2.9B$2.5B$2.6B
Borrowings$11.2B$10.1B$8.9B$8.2B$8.1B$7.1B$5.7B$5.8B$6.2B$7.5B
Other Liabilities$5.8B$4.1B$3.9B$4.0B$4.1B$3.7B$3.3B$3.2B$2.7B$2.9B
Equity$3.0M$3.0M$3.0M$3.0M$3.0M$3.0M$3.0M$3.0M$3.0M$3.0M
Reserves$9.7B$11.7B$11.3B$12.4B$12.2B$12.7B$12.0B$12.5B$12.5B$12.7B

For Zimmer Biomet Holdings, Inc., operating cash flow was positive in 10 of 10 reported years; free cash flow in the latest year was $1.5B; free cash flow was positive in 10 of 10 years; financing activities used $552.0M in the latest year, which covers debt repayment, dividends and buybacks.

Cash Flow Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Operating Cash Flow$1.6B$1.6B$1.7B$1.6B$1.2B$1.5B$1.3B$1.6B$1.5B$1.7B
Investing Cash Flow−$1.9B−$667.0M−$579.0M−$1.1B−$726.0M−$656.0M−$747.0M−$1.2B−$1.2B−$2.2B
Financing Cash Flow−$295.0M$231.0M$47.0M$133.0M$30.0M−$173.0M$418.0M−$617.0M−$825.0M−$552.0M
Net Cash Flow−$825.0M−$110.0M$18.0M$75.0M$184.0M−$324.0M−$103.0M$40.0M$110.0M$66.0M
Free Cash Flow$1.4B$1.4B$1.6B$1.2B$1.1B$1.3B$1.1B$1.2B$1.1B$1.5B

Valuation & Return Ratios

MetricValue
PEG Ratio-12.16
EV / EBITDA11.96
FCF Yield8.18%
Quick Ratio0.79
Interest Coverage4.49
Return 1Y16.98%
Return 3Y-5.49%
Return 5Y-14.30%

Zimmer Biomet Holdings, Inc. (ZBH) financials — frequently asked questions

What is Zimmer Biomet Holdings, Inc.'s annual revenue?

Zimmer Biomet Holdings, Inc. (ZBH) reported annual revenue of $8.2B in its most recent fiscal year.

What is Zimmer Biomet Holdings, Inc.'s net profit?

Zimmer Biomet Holdings, Inc. (ZBH) reported net profit of $705.0M in its most recent fiscal year.

What is ZBH EV/EBITDA?

Zimmer Biomet Holdings, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is 11.96.

Revenue and earnings of other Medical - Devices stocks

ABT revenue $44.3BISRG revenue $10.1BMDT revenue $36.4BSYK revenue $25.1BBSX revenue $20.1BEW revenue $6.1BRMD revenue $5.7BDXCM revenue $4.7BPHG revenue $17.8BGKOS revenue $507.0MAll Medical - Devices stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens
ZBH Overview ZBH Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.